Drug discovery, gene editing, and healthcare innovation from bench to bedside.
Generated November 05, 2026
| # | Ticker | Name | Industry | Stage | C1 | C2 | C3 | C4 | C5 | C6 | C7 | C8 | C9 | Total | Price | 1yr Chg | 30d Target | 90d Ret | Signal | Mkt Cap | TTM EPS | Fwd EPS | EPS Growth | Next Earnings |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | Biotechnology | AdvancingMomentum Trend | 10 | 10 | 10 | 5 | 10 | 10 | 10 | 10 | 10 | 85 | $549.04 | +30.8% | ▲ $576.50 | +13.7% | HOLD | $139.2B | $17.17 | $20.40 | +8.0% | 2026-11-02 |
| 2 | LLY | Eli Lilly and Company | Drug Manufacturers - General | AdvancingMomentum Trend | 5 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 5 | 80 | $1,417.99 | +69.0% | ▲ $1454.84 | +4.7% | HOLD | $1.3T | $30.81 | $49.46 | +16.3% | 2026-10-29 |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | Biotechnology | AdvancingMomentum Trend | 10 | 10 | 10 | 5 | 5 | 10 | 10 | 10 | 10 | 80 | $930.67 | +43.0% | ▲ $954.81 | +8.6% | HOLD | $96.3B | $45.24 | $67.57 | +35.5% | 2027-01-28 |
| 4 | ABBV | AbbVie Inc. | Drug Manufacturers - General | AdvancingMomentum Trend | 0 | 10 | 5 | 10 | 10 | 10 | 10 | 10 | 5 | 70 | $294.83 | +33.1% | ▼ $272.97 | -7.3% | WEAK | $521.0B | $5.82 | $16.16 | +2282.1% | 2026-10-30 |
| 5 | AMGN | Amgen Inc. | Drug Manufacturers - General | AdvancingMomentum Trend | 0 | 5 | 5 | 10 | 10 | 10 | 10 | 10 | 10 | 70 | $478.48 | +68.4% | ▲ $488.41 | +16.2% | HOLD | $258.7B | $16.10 | $24.50 | +64.9% | 2027-02-02 |
| 6 | ISRG | Intuitive Surgical, Inc. | Medical Instruments & Supplies | ToppingDistribution Risk | 10 | 10 | 5 | 10 | 5 | 5 | 10 | 5 | 5 | 65 | $482.10 | -9.0% | ▲ $530.74 | +22.2% | HOLD | $170.3B | $8.27 | $12.45 | -23.6% | 2027-01-21 |
| 7 | JNJ | Johnson & Johnson | Drug Manufacturers - General | AdvancingMomentum Trend | 5 | 5 | 5 | 5 | 10 | 10 | 10 | 5 | 5 | 60 | $276.32 | +49.5% | ▼ $269.56 | +1.4% | HOLD | $665.2B | $6.59 | $11.62 | -95.9% | 2027-01-26 |
| 8 | NVO | Novo Nordisk A/S | Drug Manufacturers - General | ToppingDistribution Risk | 0 | 5 | 5 | 10 | 5 | 5 | 10 | 10 | 5 | 55 | $42.18 | -11.5% | ▼ $36.44 | -12.7% | WEAK | $186.0B | $4.09 | $3.44 | -20.6% | 2026-11-04 |
| 9 | MDT | Medtronic plc | Medical Devices | AdvancingMomentum Trend | 5 | 5 | 5 | 10 | 5 | 5 | 10 | 5 | 5 | 55 | $104.96 | +19.2% | ▲ $100.32 | +11.3% | HOLD | $134.3B | $4.07 | $6.41 | +40.7% | 2026-11-24 |
| 10 | MRNA | Moderna, Inc. | Biotechnology | AdvancingMomentum Trend | 10 | 0 | 0 | 0 | 5 | 5 | 10 | 5 | 10 | 45 | $258.38 | +818.2% | ▲ $248.39 | +40.2% | HOLD | $103.2B | $-7.98 | $-4.59 | — | 2026-11-06⚡ 1d |
| # | Ticker | Name | Industry | Stage | C1 | C2 | C3 | C4 | C5 | C6 | C7 | C8 | C9 | Total | Price | 1yr Chg | 30d Target | 90d Ret | Signal | Mkt Cap | TTM EPS | Fwd EPS | EPS Growth | Next Earnings |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KYMR | Kymera Therapeutics, Inc. | Biotechnology | AdvancingMomentum Trend | 10 | 0 | 10 | 0 | 10 | 5 | 10 | 5 | 10 | 60 | $136.25 | +121.8% | ▲ $129.15 | +3.4% | HOLD | $11.6B | $-3.64 | $-5.04 | — | 2026-10-29 |
| 2 | INSM | Insmed Incorporated | Biotechnology | DecliningContrarian Setup | 5 | 5 | 10 | 10 | 5 | 0 | 10 | 5 | 10 | 60 | $110.00 | -43.4% | ▲ $124.76 | -32.9% | HOLD | $24.1B | $-2.81 | $0.56 | — | 2026-10-29 |
| 3 | DOCS | Doximity, Inc. | Health Information Services | AdvancingMomentum Trend | 10 | 5 | 10 | 10 | 0 | 5 | 10 | 5 | 5 | 60 | $34.67 | -47.3% | ▼ $13.42 | -96.7% | WEAK | $6.2B | $0.85 | $1.56 | -51.9% | 2026-11-05⚡ 0d |
| 4 | CRSP | CRISPR Therapeutics AG | Biotechnology | ToppingDistribution Risk | 10 | 5 | 5 | 0 | 5 | 5 | 10 | 5 | 10 | 55 | $51.77 | -15.3% | ▼ $36.54 | -57.0% | WEAK | $5.0B | $-4.74 | $-3.55 | — | 2026-11-02 |
| 5 | BEAM | Beam Therapeutics Inc. | Biotechnology | ToppingDistribution Risk | 10 | 0 | 5 | 0 | 5 | 5 | 10 | 5 | 10 | 50 | $27.79 | +16.8% | ▼ $23.14 | -20.6% | WEAK | $2.9B | $-0.68 | $-4.75 | — | 2026-11-03 |
| 6 | NTLA | Intellia Therapeutics, Inc. | Biotechnology | DecliningConfirmed Downtrend | 10 | 0 | 5 | 0 | 5 | 5 | 10 | 5 | 10 | 50 | $12.31 | +0.4% | ▼ $-0.62 | -138.0% | WEAK | $1.7B | $-3.35 | $-2.56 | — | 2026-11-05⚡ 0d |
| 7 | TWST | Twist Bioscience Corporation | Biotechnology | AdvancingMomentum Trend | 5 | 5 | 5 | 5 | 10 | 5 | 10 | 0 | 5 | 50 | $142.58 | +357.4% | ▲ $188.47 | +55.2% | HOLD | $9.5B | $-2.23 | $-0.40 | — | 2026-11-12⚡ 7d |
| 8 | RVMD | Revolution Medicines, Inc. | Biotechnology | AdvancingMomentum Trend | 5 | 5 | 10 | 0 | 10 | 5 | 10 | 5 | 0 | 50 | $199.70 | +239.2% | ▲ $210.67 | +16.8% | HOLD | $42.8B | $-8.87 | $-5.76 | — | 2026-11-04 |
| 9 | EDIT | Editas Medicine, Inc. | Biotechnology | ToppingDistribution Risk | 10 | 5 | 0 | 0 | 5 | 0 | 10 | 5 | 10 | 45 | $2.72 | -9.6% | ▼ $1.17 | -100.2% | WEAK | $418M | $-0.68 | $-0.75 | — | 2026-11-09⚡ 4d |
| 10 | IMVT | Immunovant, Inc. | Biotechnology | ToppingDistribution Risk | 10 | 5 | 0 | 0 | 10 | 5 | 10 | 5 | 0 | 45 | $29.90 | +20.5% | ▲ $29.63 | -2.8% | HOLD | $6.2B | $-2.82 | $-2.75 | — | 2026-11-09⚡ 4d |
| 11 | RXRX | Recursion Pharmaceuticals, Inc. | Biotechnology | AdvancingMomentum Trend | 10 | 0 | 0 | 0 | 0 | 0 | 10 | 5 | 10 | 35 | $3.88 | -31.3% | ▼ $3.24 | -15.6% | WEAK | $2.4B | $-1.00 | $-0.87 | — | 2026-11-02 |
| 12 | HIMS | Hims & Hers Health, Inc. | Drug Manufacturers - Specialty & Generic | ToppingDistribution Risk | 0 | 5 | 0 | 10 | 5 | 0 | 5 | 0 | 0 | 25 | $26.66 | -39.5% | ▼ $15.90 | -80.3% | WEAK | $6.2B | $-0.64 | $0.74 | — | 2026-11-09⚡ 4d |
| # | Ticker | Name | Industry | Stage | C1 | C2 | C3 | C4 | C5 | C6 | C7 | C8 | C9 | Total | Price | 1yr Chg | 30d Target | 90d Ret | Signal | Mkt Cap | TTM EPS | Fwd EPS | EPS Growth | Next Earnings |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETF | Pharma | Insufficient Data | 5 | 5 | 5 | 5 | 10 | 10 | 5 | 5 | 0 | 50 | $189.66 | +47.9% | — | — | — | — | — | — | — | — |